Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria
Table 3
Information on demographics, diagnosis of and treatment for AITDs, and thyroid autoantibody results of patients with AITDs.
No.
Gender
Age at CSU onset (years)
Thyroid onset relative to CU and duration between thyroid diseases and CSU (months)
Diagnosis
Treatment
Anti-Tg (+)
Anti-TPO (+)
1
Female
17
Before, 108
Grave’s disease
Oral medication, unspecified
Yes
Yes
2
Female
47
Before, 24
Grave’s disease
Propylthiouracil
Yes
No
3
Female
62
Before, NA
Grave’s disease
S/P I-131, Levothyroxine
No
No
4
Female
55
Before, 60
Hashimoto’s disease
Levothyroxine
No
Yes
5
Female
41
Before, 21
Grave’s disease
Methimazole
Yes
Yes
6
Female
48
Before, NA
Subclinical hypothyroidism
NA
Yes
Yes
7
Female
48
Before, 84
Grave’s disease
Methimazole
No
Yes
8
Female
32
After, 24
Primary hypothyroidism
Levothyroxine
Yes
Yes
9
Female
31
After, 4.5
Grave’s disease
MMI
No
Yes
10
Female
53
After, 1
Subclinical hyperthyroidism
Methimazole
Yes
Yes
11
Female
24
After, 22
Grave’s disease
Methimazole
Yes
Yes
12
Female
17
After, 25
Hashimoto’s disease
Levothyroxine
Yes
Yes
13
Female
30
After, 24
Grave’s disease
Propylthiouracil
Yes
Yes
14
Female
12
After, 60
Unclassified
NA
Yes
Yes
15
Female
62
After, 1.5
Hashimoto’s disease
Observe
Yes
Yes
16
Female
41
After, 1.5
Grave’s disease
Methimazole
Yes
No
17
Female
46
After, 26
Grave’s disease
Methimazole
Yes
No
18
Female
54
After, 21
Hashimoto’s disease
Levothyroxine
Yes
Yes
19
Female
59
After, 2
Subclinical hypothyroidism
Levothyroxine
Yes
Yes
Abbreviations Used in Table 3. AITD: autoimmune thyroid disease, CSU: chronic spontaneous urticarial, and NA: no available data.